Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec Q2 Sales Up 37%; Plans To Divest ITC To Danaher Fall Through

This article was originally published in The Gray Sheet

Executive Summary

Thoratec's second-quarter sales jumped 37% over the year-ago period, to $95.1 million, on continued adoption of the HeartMate II left ventricular assist system as both destination and bridge-to-cardiac transplant therapy, the firm reported July 29

You may also be interested in...



News In Brief

Thoratec divests ITC division

News In Brief

Thoratec divests ITC division

Thoratec Unloads Dx Equipment Unit To Danaher To Help Fund VAD Efforts

Thoratec's divestiture of hospital and home diagnostic equipment maker International Technidyne Corp. to Danaher for up to $136 million will allow greater focus on the firm's core ventricular assist device business

Related Content

Topics

UsernamePublicRestriction

Register

MT029210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel